(Q37333663)

19 August 2017

1 reference

title

Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials? (English)

1 reference

adaptive radiation therapy

19 August 2017

main subject

0 references

1 reference

3

Ralph R Weichselbaum

1 reference

19 August 2017

Ruchika Gutt

1

1 reference

19 August 2017

Stanley L Liauw

series ordinal

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

25 November 2008

1 reference

Nature Reviews Gastroenterology & Hepatology

19 August 2017

published in

1 reference

19 August 2017

volume

6

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

38-46

1 reference

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

19 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1301

Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1301

Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1301

One thousand consecutive pancreaticoduodenectomies

21 January 2018

1 reference

12 December 2020

Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicit

1 reference

12 December 2020

Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience

1 reference

12 December 2020

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

12 December 2020

Adjuvant treatment for resectable pancreatic cancer

1 reference

12 December 2020

Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head

1 reference

12 December 2020

Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil

1 reference

12 December 2020

Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).

1 reference

12 December 2020

Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12 year period

1 reference

12 December 2020

1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience

1 reference

12 December 2020

Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: Results of feasibility study

1 reference

12 December 2020

Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients

1 reference

12 December 2020

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

12 December 2020

Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data

1 reference

12 December 2020

Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings

1 reference

12 December 2020

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

12 December 2020

Adjuvant therapy of pancreatic cancer

1 reference

12 December 2020

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital

1 reference

12 December 2020

Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma

1 reference

12 December 2020

Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma

1 reference

12 December 2020

Adjuvant therapy for surgically resected pancreatic adenocarcinoma

1 reference

12 December 2020

The case for adjuvant chemoradiation for pancreatic cancer

1 reference

12 December 2020

Patterns of failure after curative resection of pancreatic carcinoma

1 reference

12 December 2020

Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.

1 reference

12 December 2020

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

12 December 2020

Adjuvant therapy of resected adenocarcinoma of the pancreas

1 reference

12 December 2020

Adjuvant therapy for pancreatic cancer: a review

1 reference

12 December 2020

Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

1 reference

12 December 2020

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

1 reference

12 December 2020

Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973—Analysis of surgical failure and implications for radiation therapy

1 reference

12 December 2020

Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial

1 reference

12 December 2020

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

1 reference

12 December 2020

Improvement of pancreatic cancer treatment from the Japanese experience in the 1980s

1 reference

12 December 2020

Recurrence of exocrine pancreatic cancer--local or hepatic?

1 reference

12 December 2020

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

12 December 2020

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

1 reference

12 December 2020

Preoperative prediction of complete resection in pancreatic cancer.

1 reference

12 December 2020

Recurrence after resection for ductal adenocarcinoma of the pancreas

1 reference

12 December 2020

Cancer statistics, 2007

1 reference

12 December 2020

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCPGASTHEP1301

1 reference

19 August 2017

1 reference